Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride

Base Information Edit
  • Chemical Name:1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride
  • CAS No.:903576-44-3
  • Molecular Formula:C17H26ClNO.ClH
  • Molecular Weight:332.30800
  • Hs Code.:
  • Mol file:903576-44-3.mol
1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride

Synonyms:Pitolisant hydrochloride;Ciproxidine;Piperidine,1-[3-[3-(4-chlorophenyl)propoxy]propyl]-,hydrochloride;

Suppliers and Price of 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • BF 2649 hydrochloride
  • 10mg
  • $ 409.00
  • TRC
  • BF2649Hydrochloride
  • 50mg
  • $ 495.00
  • Tocris
  • BF2649hydrochloride ≥98%(HPLC)
  • 50
  • $ 735.00
  • Tocris
  • BF2649hydrochloride ≥98%(HPLC)
  • 10
  • $ 171.00
  • Sigma-Aldrich
  • Pitolisant hydrochloride ≥98% (HPLC)
  • 50MG
  • $ 331.00
  • Sigma-Aldrich
  • Pitolisant hydrochloride ≥98% (HPLC)
  • 10MG
  • $ 81.60
  • DC Chemicals
  • Pitolisant hydrochloride >98%
  • 250 mg
  • $ 700.00
  • Crysdot
  • Pitolisant hydrochloride 98+%
  • 50mg
  • $ 511.00
  • Chemtos
  • Pitolisant-d5HCl
  • 10 mg
  • $ 2990.00
  • ChemScene
  • Pitolisant hydrochloride 99.91%
  • 50mg
  • $ 576.00
Total 63 raw suppliers
Chemical Property of 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride Edit
Chemical Property:
  • PSA:12.47000 
  • LogP:4.90510 
  • Storage Temp.:Desiccate at RT 
  • Solubility.:≥16.6 mg/mL in DMSO; ≥57.4 mg/mL in H2O; ≥94.2 mg/mL in EtOH 
Purity/Quality:

99% *data from raw suppliers

BF 2649 hydrochloride *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Description Pitolisant hydrochloride, a first-in-class inverse agonist of the histamine H3 receptor, was approved in the EU for the treatment of excessive daytime sleepiness (EDS) in adults with narcolepsy with or without cataplexy. The drug, which was developed by Bioprojet and has orphan drug designation in the EU and US, enhances wakefulness by increasing histaminergic neuron activity. With once daily oral administration in the morning, patients taking pitolisant exhibited significantly reduced EDS versus placebo but not versus modafinil. Plasma levels of the drug are reduced at the end of the day such that its waking effect is minimized at night (plasma t1/2 10-12 h). Several articles have been published detailing the discovery of pitolisant.
  • Uses BF 2649 Hydrochloride, is a novel histamine H3 receptor antagonist and inverse agonist.
Post RFQ for Price